Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0001104659-24-093399
Filing Date
2024-08-27
Accepted
2024-08-27 15:53:28
Documents
39

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 7926558
2 GRAPHIC lg_ascentagepharma-4clr.jpg GRAPHIC 26109
3 GRAPHIC fc_compunds-4c.jpg GRAPHIC 65458
4 GRAPHIC fc_summary-4c.jpg GRAPHIC 85482
5 GRAPHIC fc_cashflows-4c.jpg GRAPHIC 137590
6 GRAPHIC fc_olverembatinib-4c.jpg GRAPHIC 70309
7 GRAPHIC ph_mechanism-4clr.jpg GRAPHIC 86748
8 GRAPHIC tb_mutations-4c.jpg GRAPHIC 172150
9 GRAPHIC lc_cumulative-4c.jpg GRAPHIC 58472
10 GRAPHIC lc_patients-4clr.jpg GRAPHIC 33505
11 GRAPHIC bc_decreasing-4c.jpg GRAPHIC 42665
12 GRAPHIC lc_eventfreesurvival-4clr.jpg GRAPHIC 43902
13 GRAPHIC bc_monotherapy-4c.jpg GRAPHIC 44428
14 GRAPHIC bc_response-4c.jpg GRAPHIC 58247
15 GRAPHIC bc_molecular-4clr.jpg GRAPHIC 30684
16 GRAPHIC bc_threemonths-4clr.jpg GRAPHIC 18698
17 GRAPHIC lc_median-4clr.jpg GRAPHIC 29321
18 GRAPHIC fc_regtrials-4c.jpg GRAPHIC 32658
19 GRAPHIC fc_polaris1-4c.jpg GRAPHIC 36116
20 GRAPHIC fc_polaris2-4clr.jpg GRAPHIC 75757
21 GRAPHIC fc_lisaftoclax-4c.jpg GRAPHIC 73919
22 GRAPHIC ph_apoptosome-4clr.jpg GRAPHIC 67653
23 GRAPHIC lc_bestoverallres-4c.jpg GRAPHIC 101661
24 GRAPHIC fc_dialydose-4c.jpg GRAPHIC 41058
25 GRAPHIC tb_combination-4c.jpg GRAPHIC 34939
26 GRAPHIC bc_efficacyreports-4c.jpg GRAPHIC 58652
27 GRAPHIC tb_amlpatients-4c.jpg GRAPHIC 53450
28 GRAPHIC tb_safetyresults-4c.jpg GRAPHIC 73591
29 GRAPHIC tb_44patiens-4c.jpg GRAPHIC 87495
30 GRAPHIC bc_synergistic-4clr.jpg GRAPHIC 136267
31 GRAPHIC fc_lisareggrials-4c.jpg GRAPHIC 53616
32 GRAPHIC fc_glora-4c.jpg GRAPHIC 51050
33 GRAPHIC fc_glora2-4c.jpg GRAPHIC 50245
34 GRAPHIC fc_glora3-4c.jpg GRAPHIC 55325
35 GRAPHIC fc_candidates-4c.jpg GRAPHIC 30396
36 GRAPHIC ph_alrizomadlin-4clr.jpg GRAPHIC 121607
37 GRAPHIC fc_carcinoma-4c.jpg GRAPHIC 79032
38 GRAPHIC bc_selectclinical-4c.jpg GRAPHIC 58026
39 GRAPHIC ph_anemia-4clr.jpg GRAPHIC 73637
  Complete submission text file 0001104659-24-093399.txt   11265695
Mailing Address 68 XINQING ROAD SUZHOU INDUSTRIAL PARK SUZHOU , JIANGSU F4 00000
Business Address 68 XINQING ROAD SUZHOU INDUSTRIAL PARK SUZHOU , JIANGSU F4 00000 86 512 8555 7777
ASCENTAGE PHARMA GROUP INTERNATIONAL (Filer) CIK: 0002023311 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-07274 | Film No.: 241248803
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)